Table 3– Crude and adjusted OR for mortality in subjects with chronic obstructive pulmonary disease hospitalised for pneumonia by prior outpatient use of inhaled corticosteroids (ICS)

	ICS		Crude OR (95% CI)	Adjusted OR (95% CI)	p-value
	Use	Non-use
Subjects	2420 (38.1)	3933 (61.9)
30-day mortality	133 (6)	433 (11)	0.64 (0.51–0.81)	0.76 (0.70–0.83)	<0.001
90-day mortality	282 (12)	734 (19)	0.74 (0.62–0.87)	0.80 (0.75–0.86)	<0.001

Data are presented as n (%), unless otherwise stated.